Streitkultur and the governance of genetic testing and insurance in Germany

被引:2
|
作者
Lander, Jonas [1 ]
Van Hoyweghen, Ine [2 ]
机构
[1] Hannover Med Sch, Inst Geschichte Eth & Philosophie Med, Hannover, Germany
[2] Katholieke Univ Leuven, Fac Social Sci, Ctr Sociol Res CeSO, Leuven, Belgium
关键词
policy analysis; political cultures; genetic discrimination; governance of genetic technologies; GenDG; TECHNOLOGIES; PARTICIPATION; SCIENCE;
D O I
10.1080/14636778.2013.873336
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rapid developments in genetic testing have given rise to fundamental ethical, legal, and social questions that need to be dealt with in society. Results of genetic tests may be of interest to third parties such as private insurance companies, leading to fears of genetic discrimination. In Germany, the Government adopted the Genetic Diagnosis Act (Gendiagnostikgesetz, GenDG) in 2009 to protect people from, inter alia, genetic discrimination in obtaining life or health insurance. Given the sensitivity of the topic, this legislation was continually revised between 2001 and 2009. In this article, we reconstruct the process of formulating the GenDG with regard to genetics and insurance. The article begins with the parliamentary Enquete Commission in 2000 to develop a strategy and recommendations for the governance of genetic diagnostics, and analyzes how these recommendations were applied during the legislative process. We demonstrate that the legislative process of GenDG was largely determined by conventional methods of governance, rather than Streitkultur called for by the Enquete Commission in 2002. We conclude that though Streitkultur was defined as a mechanism to develop a robust approach to the governance of genetic diagnostics, it failed to influence a crucial element in genetic testing and insurance; namely, to fully protect insurees from genetic discrimination.
引用
收藏
页码:42 / 59
页数:18
相关论文
共 50 条
  • [21] The impact of genetic testing on healthcare insurance
    Hoy, M
    Orsi, F
    Eisinger, F
    Moatti, JP
    [J]. GENEVA PAPERS ON RISK AND INSURANCE-ISSUES AND PRACTICE, 2003, 28 (02): : 203 - 221
  • [22] Germany plans to ban genetic tests by insurance companies
    Weber, W
    [J]. LANCET, 2001, 357 (9260): : 943 - 943
  • [23] PROSPECTS FOR USING THE RESULTS OF GENETIC TESTING IN INSURANCE
    Suvorova, Ekaterina Ilinichna
    Nikiforov, Vladimir Vladimirovich
    Zenin, Sergey Sergeevich
    Zaikin, Sergey Sergeevich
    Bartsits, Henri Lvovich
    [J]. REVISTA INCLUSIONES, 2020, 7 : 615 - 627
  • [24] HEALTH INSURANCE, GENETIC TESTING AND ADVERSE SELECTION
    MacMinn, R. D.
    Brockett, P. L.
    Raeburn, J. A.
    [J]. ANNALS OF ACTUARIAL SCIENCE, 2007, 2 (02) : 327 - 347
  • [25] INSURANCE AND GENETIC TESTING - WHERE ARE WE NOW
    OSTRER, H
    ALLEN, W
    CRANDALL, LA
    MOSELEY, RE
    DEWAR, MA
    NYE, D
    VANMCCRARY, S
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 52 (03) : 565 - 577
  • [26] Genetic testing and insurance: opportunities and challenges for society
    Mossialos, E
    Dixon, A
    [J]. TRENDS IN MOLECULAR MEDICINE, 2001, 7 (07) : 323 - 324
  • [27] GENETIC TESTING AND INSURANCE - COMPLICATED BY POLYGENIC DISEASES
    SMYTH, E
    STEEL, M
    ANDERSON, E
    [J]. BRITISH MEDICAL JOURNAL, 1994, 308 (6926): : 472 - 472
  • [28] Genetic testing and insurance: When is discrimination justified?
    David Keays
    [J]. Monash Bioethics Review, 2000, 19 (4) : S79 - S88
  • [29] Genetic Testing and Insurance: The Complexity of Adverse Selection
    Durnin, Maureen
    Hoy, Michael
    Ruse, Michael
    [J]. ETHICAL PERSPECTIVES, 2012, 19 (01) : 123 - 154
  • [30] Genetic testing and disability insurance: An alternative opinion
    Dodge, John H.
    Christianson, David J.
    [J]. JOURNAL OF LAW MEDICINE & ETHICS, 2007, 35 : 33 - 35